Kopran Limited
Kopran Limited is an Indian listed company in the Pharmaceuticals & Biotechnology industry (Healthcare sector), traded under NSE: KOPRAN and BSE: 524280 (ISIN INE082A01010).
It has a market capitalisation of ₹1,344 crore, a last close of ₹278.25 on 2026-10-19, a one-year return of 67.5%.
Valuation: a price-to-earnings ratio of 53.78x, a price-to-book ratio of 2.53x, a dividend yield of 1.1%.
Profitability: return on equity of 0.0%, return on capital employed of 7.8%, an operating margin of 8.7%.
Growth: sales growth of 7.3% a year over three years.
Balance sheet and ownership: debt-to-equity of 0.29x, promoter holding of 41.8%.
| Metric | Value |
|---|---|
| Market capitalisation | 1,344 |
| Last close | ₹278.25 |
| P/E (TTM) | 53.78x |
| P/B | 2.53x |
| Dividend yield | 1.1% |
| ROE (FY) | 0.0% |
| ROCE (FY) | 7.8% |
| Operating margin (TTM) | 8.7% |
| Sales growth, 3-year CAGR | 7.3% |
| Debt / equity | 0.29x |
| Promoter holding | 41.8% |
| 1-year return | 67.5% |
Loading the live page with the price chart, financial history, shareholding and recent filings. Data is end-of-day and rebuilt nightly; nothing here is investment advice. Financial statements · What each metric means